Tech Center 1600 • Art Units: 1682
This examiner grants 54% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17668915 | MATERIALS AND METHODS FOR DETERMINING CANCER RISK | Final Rejection | Mayo Foundation for Medical Education and Research |
| 18298922 | TRANSMEMBRANE NANOSENSOR ARRAYS FOR RAPID, ULTRA-SENSITIVE AND SPECIFIC DIGITAL QUANTIFICATION OF INTERNAL MICRO-RNA CONTENT OF INTACT EXOSOMES | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 18246456 | METHOD FOR PREDICTING IMMUNOTHERAPY RESISTANCE | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 17793382 | COMPOSITIONS AND METHODS FOR DETECTION OF OVARIAN CANCER | Final Rejection | Mercy BioAnalytics, Inc. |
| 18028432 | NUCLEIC ACID NANOSTRUCTURES WITH TUNABLE FUNCTIONAL STABILITY | Non-Final OA | National University of Singapore |
| 18323143 | Double-Stranded DNA Deaminases and Uses Thereof | Non-Final OA | New England Biolabs, Inc. |
| 17780926 | UPPER URINARY TRACT UROTHELIAL CARCINOMA IDENTIFICATION METHOD | Final Rejection | KEIO UNIVERSITY |
| 18006888 | BIOMARKERS FOR DIAGNOSING AND MONITORING LUNG CANCER | Non-Final OA | SORBONNE UNIVERSITE |
| 18075729 | METHODS, COMPOSITIONS, AND KITS FOR DETECTING ALLELIC VARIANTS | Non-Final OA | LIFE TECHNOLOGIES CORPORATION |
| 17760652 | HUMAN MITOCHONDRIAL DNA SEQUENCING BY TARGETED AMPLIFICATION OF MULTIPLEX PROBES (MTDNA-STAMP) | Final Rejection | CORNELL UNIVERSITY |
| 17786373 | CANCER SIGNATURES, METHODS OF GENERATING CANCER SIGNATURES, AND USES THEREOF | Final Rejection | EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE |
| 17778204 | METHOD FOR DOUBLE STRAND SEQUENCING | Final Rejection | Oxford Nanopore Technologies PLC |
| 17384241 | DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE | Final Rejection | GRAIL, LLC |
| 17890694 | METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING SUBJECTS AT RISK OF POOR CANCER SURVIVAL | Non-Final OA | MEMORIAL SLOAN-KETTERING CANCER CENTER |
| 17600531 | METHOD OF CLASSIFYING A SAMPLE BASED ON DETERMINATION OF FGFR | Non-Final OA | UNIVERSITÄT HEIDELBERG |
| 17640740 | DETECTION OF CHLAMYDIA TRACHOMATIS NUCLEIC ACID VARIANTS | Final Rejection | Gen-Probe Incorporated |
| 17632783 | CANCER DETECTION AND CLASSIFICATION | Final Rejection | The United States of America, as represented by the Secretary, Department of Health and Human Servic |
| 18450653 | KIT FOR IDENTIFYING TUMOR TISSUE-OF-ORIGIN AND DATA ANALYSIS METHOD | Non-Final OA | Hangzhou ShengTing Medical Technology Ltd. |
| 18253582 | METHOD FOR ISOLATING NUCLEIC ACID USING BINDING BUFFER INCLUDING COMPOUND HAVING LOW OR INTERMEDIATE DIELECTRIC CONSTANT | Non-Final OA | BIONEER CORPORATION |
| 18254179 | Ribosomal profiling in single cells | Non-Final OA | Koninklijke Nederlandse Akademie van Wetenschappen |
| 18036733 | METHOD FOR ASSISTING DETERMINATION ON SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, METHOD FOR DETERMINING SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, METHOD FOR COLLECTING DATA FOR USE IN DETERMINATION ON SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, METHOD FOR DIAGNOSING SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, IN VITRO METHOD FOR ASSISTING DETERMINATION ON SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, ... | Non-Final OA | Public University Corporation Nagoya City University |
| 18246643 | TREATMENT RESPONSE PREDICTIVE METHOD | Non-Final OA | Breast Cancer Now |
| 17309902 | METHYLATION MODIFICATION-BASED TUMOR MARKER STAMP-EP6 | Non-Final OA | SHANGHAI EPIPROBE BIOTECHNOLOGY CO., LTD. |
| 17309898 | TUMOR MARKER STAMP-EP3 BASED ON METHYLATION MODIFICATION | Non-Final OA | SHANGHAI EPIPROBE BIOTECHNOLOGY CO., LTD. |
| 17716395 | CELL-FREE DNA METHYLATION AND NUCLEASE-MEDIATED FRAGMENTATION | Final Rejection | GRAIL, Inc. |
| 18075464 | NOVEL TUMOR MARKER FOR HEPATOCELLULAR CARCINOMA AND CLINICAL APPLICATION THEREOF | Non-Final OA | The First Affiliated Hospital of Sun Yat-Sen University |
| 17770807 | SAMPLE PREPARATION AND SEQUENCING ANALYSIS FOR REPEAT EXPANSION DISORDERS AND SHORT READ DEFICIENT TARGETS | Final Rejection | JumpCode Genomics, Inc. |
| 17757847 | METHOD OF DETECTING EPIGENETIC MODIFICATION | Final Rejection | Biofidelity Ltd |
| 17787114 | COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING A MYCOBACTERIUM TUBERCULOSIS INFECTION | Non-Final OA | San Diego State University (SDSU )Foundation, dba San Diego State University Research Foundation |
| 17714271 | METHOD FOR DETERMINING WHETHER BIOLOGICAL SAMPLE HASORIGINATED FROM LIVER CANCER TISSUE | Non-Final OA | LEPIDYNE CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy